Mingxing Zhou

Mingxing Zhou has worked in the field for over two decades. Mingxing began their career in 1997 as a Research Fellow at Atrix. Mingxing then held a Research Fellow position at QLT Inc. from 2004 to 2008. From 2008 to 2016, they worked as a Research Fellow at RB Pharma. Mingxing then transitioned to a Research Fellow role at Indivior from 2016 to 2020. Most recently, they have been a Director at CSPC Dophen Corporation since 2020 and at JOINN Biologics US Inc. since 2021.

Mingxing Zhou attended the Medical University of South Carolina from 1990 to 1995 and obtained a Doctor of Philosophy - PhD in Pharmaceutical Sciences.